From: Efficacy of rTMS for poststroke epilepsy and its effects on patients’ cognitive function and depressive status
n
No adverse reactions
Dizziness
Headache
Nausea
drowsiness
Incidence of adverse reactions (%)
χ2
P
Treated
53
45
2
3
1
13.46
0.001
0.971
Control
68
59
13.24